06/24/2025
4:40 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:33 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
10:18 AM | Halozyme Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
05/02/2025
3:04 PM | Duncan Barbara Gayle (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:06 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:07 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:08 PM | Halozyme Therapeutics (Issuer)
Krishnan Mahesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
5:04 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:18 PM | BlackRock, Inc. (Filed by)
Halozyme Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/01/2025
5:32 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:17 PM | Halozyme Therapeutics (Filer)
| Form ARS | |
Get the Latest News and Ratings for HALO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/18/2025
3:10 PM | Halozyme Therapeutics (Filer)
| Form DEF 14A | |
03/03/2025
7:46 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:32 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:32 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
4:07 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:11 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:49 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:50 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:52 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:47 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:37 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:39 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:41 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:12 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:08 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:09 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:11 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:07 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:21 PM | Halozyme Therapeutics (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:00 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:14 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:12 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:26 PM | Halozyme Therapeutics (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
8:36 AM | Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G/A | |
10/31/2024
3:05 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
8:36 AM | Halozyme Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
10/16/2024
5:53 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:14 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:34 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
4:39 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The $100 Trillion AI Story No One Is Telling You (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
10/09/2024
3:09 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:08 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
5:06 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:00 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/24/2024
3:05 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
5:49 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:01 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
4:56 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:12 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:05 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:16 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
6:49 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:03 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:16 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
3:59 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:31 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:19 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:41 PM | Halozyme Therapeutics (Subject)
Posard Matthew L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:48 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:11 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
3:13 PM | Halozyme Therapeutics (Subject)
LaBrosse Nicole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
